Akèy › Skleroz Miltip › Michigan
Etid klinik pou Skleroz Miltip nan Michigan
10 etid pou Skleroz Miltip ap chèche patisipan nan sit nan Michigan.
Vil nan Michigan
Tèks ofisyèl etid la (Anglè)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Ann Arbor
- TG Therapeutics Investigational Trial Site, Detroit
- TG Therapeutics Investigational Trial Site, Farmington
- ak 2 plis
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT06433752RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Michigan, Ann Arbor
- Henry Ford Health, Novi
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Michigan Institute for Neurological Disorders- Site Number : 8400004, Farmington Hills
Ap rekriteFaz 3
Laj 18 a 60 · Tout sèks · Mizajou Sep 15, 2026 · NCT07325292A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Northwest Neurology, Southfield
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Sep 9, 2026 · NCT06782490A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Ann Arbor
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06680037Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
- Kahana Oculoplastic and Orbital Surgery, Livonia
Ap rekriteFaz 3
Laj 18 a 50 · Tout sèks · Mizajou Aug 14, 2026 · NCT07623668A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Michigan Institute of Neurological, Farmington Hills
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Jul 29, 2026 · NCT07225504Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
- University of Michigan, Ann Arbor
Ap rekriteFaz 2
Laj 18 a 65 · Tout sèks · Mizajou Jul 17, 2026 · NCT05269628A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
- Quest Research Institute, Farmington Hills
Ap rekriteFaz 2
Laj 18 a 55 · Tout sèks · Mizajou Jun 15, 2026 · NCT06735248Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
- Wayne State University, Detroit
Ap rekriteEtid obsèvasyon
Laj 18 a 60 · Tout sèks · Mizajou Jun 6, 2022 · NCT04458688Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.